Lv, J., & Lin, J. (2020). Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment. Asian J Androl.
Chicago Style CitationLv, Jialu, and Jianqing Lin. "Relugolix As a Promising Novel Oral GnRH Antagonist for Prostate Cancer Treatment." Asian J Androl 2020.
MLA CitationLv, Jialu, and Jianqing Lin. "Relugolix As a Promising Novel Oral GnRH Antagonist for Prostate Cancer Treatment." Asian J Androl 2020.
Warning: These citations may not always be 100% accurate.